2Desai KV, Xiao N, Wang W, et al. Initiating oncogenic event determines gene-expression patterns of humam breast cancer models. Proc Natl Acad Sci U S A, 2002,99 (10) : 6967-6972.
3Small GW, Chou TY, Dang CV, et al. Evidence for involvement of calpain in c-myc proteolysis in vivo. Arch Biochem Biophs, 2002,400(2):151-161.
4Claus EB, Schildkraut J, Iversen ES, et al. Effect of BRCAx and BRCA2 on the association between breast cancer risk and familyhist ory. J Natl Cancer Inst,1998,90:1824.
5Borresen-Dale AL. pss and breast cancer. Hum Mutat, 2003,21 (3) :292 - 300.
6Lehann U, Langer F, Feist H, et al. Quantitative assessment of promoter hypermethylation during breast cancer development. Am J Pathol, 2002,160: 605-612.
7Walker RA, Jones JL, Chappel SA, et al. Molecular pathology of breast cancer and its application to clinical management. Cancer and Metastasis Reviews, 1997,16 :5.
8Zaffaroni N, Della Porta C, Villa R, et al. Transcription and alternative splicing of telomerase transeriptase in benign and malignant breast tumors and in adjacent mammary glandular tissues: implications for telomerase activity. J Pathol, 2002, 198 (1):37.
二级参考文献2
1许良中，Chinese Journal of Cancer Research，1989年，1卷，61页
